<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Blood Adv</journal-id>
<journal-id journal-id-type="iso-abbrev">Blood Adv</journal-id>
<journal-id journal-id-type="hwp">bloodoa</journal-id>
<journal-id journal-id-type="pmc">Blood Adv</journal-id>
<journal-id journal-id-type="publisher-id">Blood Advances</journal-id>
<journal-title-group>
<journal-title>Blood Advances</journal-title>
</journal-title-group>
<issn pub-type="ppub">2473-9529</issn>
<issn pub-type="epub">2473-9537</issn>
<publisher>
<publisher-name>American Society of Hematology</publisher-name>
<publisher-loc>Washington, DC</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29296947</article-id>
<article-id pub-id-type="pmc">5744036</article-id>
<article-id pub-id-type="publisher-id">2016/000943</article-id>
<article-id pub-id-type="doi">10.1182/bloodadvances.2016000943</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>22</subject>
<subject>25</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Myeloid Neoplasia</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Reina-Castillón</surname>
<given-names>Judith</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pujol</surname>
<given-names>Roser</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>López-Sánchez</surname>
<given-names>Marcos</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rodríguez-Santiago</surname>
<given-names>Benjamín</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aza-Carmona</surname>
<given-names>Miriam</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>González</surname>
<given-names>Juan Ramón</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff5">5</xref>
<xref ref-type="aff" rid="aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Casado</surname>
<given-names>José Antonio</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff8">8</xref>
<xref ref-type="aff" rid="aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bueren</surname>
<given-names>Juan Antonio</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff8">8</xref>
<xref ref-type="aff" rid="aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sevilla</surname>
<given-names>Julián</given-names>
</name>
<xref ref-type="aff" rid="aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Badel</surname>
<given-names>Isabel</given-names>
</name>
<xref ref-type="aff" rid="aff11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Català</surname>
<given-names>Albert</given-names>
</name>
<xref ref-type="aff" rid="aff12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Beléndez</surname>
<given-names>Cristina</given-names>
</name>
<xref ref-type="aff" rid="aff13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dasí</surname>
<given-names>María Ángeles</given-names>
</name>
<xref ref-type="aff" rid="aff14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Díaz de Heredia</surname>
<given-names>Cristina</given-names>
</name>
<xref ref-type="aff" rid="aff15">15</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Soulier</surname>
<given-names>Jean</given-names>
</name>
<xref ref-type="aff" rid="aff16">16</xref>
<xref ref-type="aff" rid="aff17">17</xref>
<xref ref-type="aff" rid="aff18">18</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schindler</surname>
<given-names>Detlev</given-names>
</name>
<xref ref-type="aff" rid="aff19">19</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Pérez-Jurado</surname>
<given-names>Luis Alberto</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Surrallés</surname>
<given-names>Jordi</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="aff" rid="aff20">20</xref>
</contrib>
<aff id="aff1"><label>1</label>Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain;</aff>
<aff id="aff2"><label>2</label>Hospital del Mar Research Institute, Barcelona, Spain;</aff>
<aff id="aff3"><label>3</label>Centro de Investigación Biomédica en Red de Enfermedades Raras, Barcelona, Spain;</aff>
<aff id="aff4"><label>4</label>Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Spain;</aff>
<aff id="aff5"><label>5</label>Centre for Research in Environmental Epidemiology, ISGlobal, Barcelona, Spain,</aff>
<aff id="aff6"><label>6</label>qGenomics Laboratory, Esplugues de Llobregat, Spain;</aff>
<aff id="aff7"><label>7</label>Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Barcelona, Spain,</aff>
<aff id="aff8"><label>8</label>Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain;</aff>
<aff id="aff9"><label>9</label>Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain;</aff>
<aff id="aff10"><label>10</label>Hematology Service, Hospital Niño Jesús, Madrid, Spain;</aff>
<aff id="aff11"><label>11</label>Pediatrics Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain;</aff>
<aff id="aff12"><label>12</label>Hematology Service, Hospital Sant Joan de Déu, Esplugues de Llobregat, Spain;</aff>
<aff id="aff13"><label>13</label>Oncohematology Service, Hospital Gregorio Marañón, Madrid, Spain;</aff>
<aff id="aff14"><label>14</label>Hematology Service, Hospital Universitario la Fe, Valencia, Spain,</aff>
<aff id="aff15"><label>15</label>Hemato-Oncology Service, Hospital Maternoinfantil Vall d'Hebron, Barcelona, Spain;</aff>
<aff id="aff16"><label>16</label>Institute of Hematology, Université Paris-Diderot, Sorbonne Paris Cité, Paris, France;</aff>
<aff id="aff17"><label>17</label>INSERM, Unité Mixte de Recherche 944, and</aff>
<aff id="aff18"><label>18</label>Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7212, Saint-Louis Hospital, Paris, France;</aff>
<aff id="aff19"><label>19</label>Department of Human Genetics, University of Würzburg, Würzburg, Germany; and</aff>
<aff id="aff20"><label>20</label>Genetics Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain</aff>
</contrib-group>
<pub-date pub-type="collection">
<day>24</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>23</day>
<month>1</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>1</volume>
<issue>5</issue>
<fpage>319</fpage>
<lpage>329</lpage>
<history>
<date date-type="received">
<day>29</day>
<month>8</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 by The American Society of Hematology</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri xlink:href="advances000943.pdf" xlink:title="pdf"></self-uri>
<self-uri xlink:href="advances000943_thumb.jpg" xlink:role="icon"></self-uri>
<abstract abstract-type="executive-summary">
<title>Key Points</title>
<p>
<list list-type="bullet">
<list-item>
<p>Fanconi anemia patients have exacerbated cytogenetic clonal mosaicism as detected by molecular karyotyping of blood DNA with SNP assays.</p>
</list-item>
<list-item>
<p>Bone marrow clonal abnormalities can be detected in blood DNA and used as biomarkers of cancer risk and poor prognosis.</p>
</list-item>
</list>
</p>
</abstract>
<abstract>
<p>Detectable clonal mosaicism for large chromosomal events has been associated with aging and an increased risk of hematological and some solid cancers. We hypothesized that genetic cancer predisposition disorders, such as Fanconi anemia (FA), could manifest a high rate of chromosomal mosaic events (CMEs) in peripheral blood, which could be used as early biomarkers of cancer risk. We studied the prevalence of CMEs by single-nucleotide polymorphism (SNP) array in 130 FA patients’ blood DNA and their impact on cancer risk. We detected 51 CMEs (4.4-159 Mb in size) in 16 out of 130 patients (12.3%), of which 9 had multiple CMEs. The most frequent events were gains at 3q (n = 6) and 1q (n = 5), both previously associated with leukemia, as well as rearrangements with breakpoint clustering within the major histocompatibility complex locus (<italic>P</italic> = 7.3 × 10<sup>−9</sup>). Compared with 15 743 age-matched population controls, FA patients had a 126 to 140 times higher risk of detectable CMEs in blood (<italic>P</italic> &lt; 2.2 × 10<sup>−16</sup>). Prevalent and incident hematologic and solid cancers were more common in CME carriers (odds ratio [OR] = 11.6, 95% confidence interval [CI] = 3.4-39.3, <italic>P</italic> = 2.8 × 10<sup>−5</sup>), leading to poorer prognosis. The age-adjusted hazard risk (HR) of having cancer was almost 5 times higher in FA individuals with CMEs than in those without CMEs. Regarding survival, the HR of dying was 4 times higher in FA individuals having CMEs (HR = 4.0, 95% CI = 2.0-7.9, <italic>P</italic> = 5.7 × 10<sup>−5</sup>). Therefore, our data suggest that molecular karyotyping with SNP arrays in easy-to-obtain blood samples could be used for better monitoring of bone marrow clonal events, cancer risk, and overall survival of FA patients.</p>
</abstract>
<abstract abstract-type="graphical">
<title>Visual Abstract</title>
<p>
<fig fig-type="featured" id="absf1" orientation="portrait" position="float">
<graphic xlink:href="advances000943absf1"></graphic>
</fig>
</p>
</abstract>
<counts>
<page-count count="11"></page-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>access</meta-name>
<meta-value>free</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>